These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15552863)
21. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. Kato K No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861 [No Abstract] [Full Text] [Related]
23. What matters is not the differences between triptans, but the differences between patients. Saper JR Arch Neurol; 2001 Sep; 58(9):1481-2. PubMed ID: 11559323 [No Abstract] [Full Text] [Related]
24. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Pascual J; Fité B; López-Gil A Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301 [TBL] [Abstract][Full Text] [Related]
25. Sumatriptan versus eletriptan: which is best? Dodick DW Lancet Neurol; 2002 Dec; 1(8):474. PubMed ID: 12849329 [No Abstract] [Full Text] [Related]
26. [Treatment of migraine in patients with hypertension and ischemic heart disease]. Ficzere A; Csiba L Ideggyogy Sz; 2002 Jan; 55(1-2):25-9. PubMed ID: 12122940 [TBL] [Abstract][Full Text] [Related]
27. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Ashcroft DM; Millson D Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068 [TBL] [Abstract][Full Text] [Related]
32. Correlation between lipophilicity and triptan outcomes. Pascual J; Muñoz P Headache; 2005 Jan; 45(1):3-6. PubMed ID: 15663606 [TBL] [Abstract][Full Text] [Related]
33. New "triptans" and other drugs for migraine. Med Lett Drugs Ther; 1998 Oct; 40(1037):97-100. PubMed ID: 9793036 [No Abstract] [Full Text] [Related]
34. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Deleu D; Hanssens Y Neurology; 2003 Apr; 60(7):1221-2; author reply 1221-2. PubMed ID: 12682349 [No Abstract] [Full Text] [Related]
35. Multiple attack study on the available triptans in Italy versus placebo. Vollono C; Capuano A; Mei D; Ferraro D; Pierguidi L; Evangelista M; Di Trapani G Eur J Neurol; 2005 Jul; 12(7):557-63. PubMed ID: 15958097 [TBL] [Abstract][Full Text] [Related]
36. Acute management of migraine: triptans and beyond. Diener HC; Limmroth V Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171 [TBL] [Abstract][Full Text] [Related]
38. A comment on time-to-event analysis for headache relief. Tfelt-Hansen P Cephalalgia; 2000 May; 20(4):255-6. PubMed ID: 10999677 [No Abstract] [Full Text] [Related]
39. Building on the sumatriptan experience: the development of naratriptan. Connor HE Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820 [No Abstract] [Full Text] [Related]